InnovAge HoldingINNV +2.57%66 Days Payable is 38.59 as of Mar. 2026, which is 24% above its 10-year median of 31.21. GuruFocus rates INNV with a GF Score™ of 66/100 and a GF Value™ of $6.53 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 607 Healthcare Providers & Services companies, InnovAge Holding ranks worse than 68.37% on this metric.
The historical rank and industry rank for InnovAge Holding's Days Payable or its related term are showing as below:
INNV'
s Days Payable Range Over the Past 10 Years
Min: 24.1 Med: 31.21 Max: 35.8
Current: 35.8
During the past 7 years, InnovAge Holding's highest Days Payable was 35.80. The lowest was 24.10. And the median was 31.21.
INNV's Days Payable is ranked worse than 68.37% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 58
vs INNV: 35.80
InnovAge Holding's Days Payable
increased
from Mar. 2025 (34.26) to Mar. 2026 (38.59).
It may suggest that InnovAge Holdingdelayed paying its suppliers.
InnovAge Holding Days Payable Related Terms
InnovAge Holding Days Payable Historical Data
* Premium members only.
The historical data trend for InnovAge Holding's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, InnovAge Holding's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InnovAge Holding Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, InnovAge Holding's Days Payable distribution charts can be found below:
* The bar in red indicates where InnovAge Holding's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
InnovAge Holding's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InnovAge Holding (INNV) has a Days Payable of 38.59 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on InnovAge Holding and its competitors. This is 24% above median its historical median of 31.21. Over the past decade, InnovAge Holding's Days Payable has ranged from 24.10 to 35.80. According to the industry distribution chart, InnovAge Holding ranks #415 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 68.4%.
Is InnovAge Holding's Days Payable too high?
InnovAge Holding's current Days Payable of 38.59 is 24% above median its 10-year median of 31.21. Over the past 10 years, this metric has ranged from a low of 24.10 to a high of 35.80. The Healthcare Providers & Services industry median Days Payable is 58.00. InnovAge Holding's value of 38.59 is 33.5% below this industry median. Based on the distribution chart, InnovAge Holding ranks #415 out of 607 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, InnovAge Holding has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InnovAge Holding's Days Payable compare to ARDT and AMN?
According to the Healthcare Providers & Services industry distribution chart, InnovAge Holding ranks #415 out of 607 companies for Days Payable. This places InnovAge Holding in the lower half of its industry. The industry median Days Payable is 58.00. InnovAge Holding's value of 38.59 is 33.5% below this benchmark. Historically, InnovAge Holding's own Days Payable has ranged from 24.10 to 35.80 over the past decade. While the company's 10-year median is 31.21 vs. the industry median of 58.00, InnovAge Holding has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.00, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InnovAge Holding's current Days Payable of 38.59 is 33.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on InnovAge Holding and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InnovAge Holding's current Days Payable is 38.59, which is 24% above median its own 10-year median of 31.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InnovAge Holding stock overvalued right now?
Based on GuruFocus' analysis, InnovAge Holding (INNV) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.53, compared to a current price of $12.00 — trading 83.7% above its estimated fair value. The current Days Payable is 38.59, which is 24% above median its 10-year median of 31.21 and 33.5% below the Healthcare Providers & Services industry median of 58.00. InnovAge Holding's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For InnovAge Holding (INNV), the current Days Payable is 38.59 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InnovAge Holding (INNV) Overvalued in 2026?
Based on GuruFocus' analysis, InnovAge Holding stock appears to be overvalued.
The current stock price of $12.00 is trading 83.7% above its estimated GF Value™ of $6.53.
GuruFocus considers InnovAge Holding to be Significantly Overvalued.
Key valuation signals for INNV:
Days Payable: 38.59 (24% above median its 10-year median of 31.21)
GF Value™: $6.53 vs. price of $12.00 (83.7% above fair value)
Industry Position: 33.5% below the Healthcare Providers & Services median (#415 of 607)
No single metric tells the full story. See the INNV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.
66GF Score
Get the complete analysis for INNV
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INNV has been successfully added to your 
